Related Experiment Videos
A method for testing for epinephrine-induced arrhythmias in rats
M J Laster1, B H Johnson, E I Eger
1Department of Anesthesia, University of California, San Francisco 94143-0464.
Anesthesia and Analgesia
|June 1, 1990
Summary
A new rat model efficiently screens inhaled anesthetics for arrhythmia potential. This method uses sensitive rats and epinephrine to predict anesthetic risks, reducing costs and animal use in drug development.
Area of Science:
- Anesthesiology
- Pharmacology
- Cardiovascular Research
Background:
- Evaluating new inhaled anesthetics for arrhythmia risk is crucial but resource-intensive.
- Current methods often require larger animal models, increasing logistic and economic burdens.
- A need exists for a more efficient screening technique.
Purpose of the Study:
- To develop and validate a novel rat model for assessing the arrhythmogenic potential of inhaled anesthetics.
- To reduce the number of animals and resources required for preclinical anesthetic safety evaluation.
Main Methods:
- Selection of male rats exhibiting sensitivity to epinephrine-induced arrhythmias.
- Testing anesthetic agents (halothane, isoflurane) in these selected rats.
- Quantification of epinephrine dose required to induce premature ventricular extrasystoles under different anesthetic concentrations.
Main Results:
- Rats exposed to 1.4% halothane required 2.4 +/- 1.0 µg/kg epinephrine for arrhythmias.
- Rats exposed to 1.6%-2.2% isoflurane required 28 +/- 24 µg/kg epinephrine for arrhythmias.
- The dose difference observed in rats is approximately two to three times that seen in humans.
Conclusions:
- The developed rat model effectively differentiates the arrhythmogenic potential of inhaled anesthetics.
- This model offers a cost-effective and efficient alternative for preclinical screening of new anesthetics.
- Findings suggest potential species-specific differences in anesthetic-induced arrhythmia sensitivity.